Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
British Journal of Cancer|August 26, 1998
Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancerS Petrasch, A Welt, A Reinacher, et al.Zeitschrift Fur Gastroenterologie|February 20, 1999
Helicobacter pylori induces apoptosis in mucosal lymphocytes in patients with gastritisA Reinacher-Schick, S Petrasch, A Burger, et al.Respiration; International Review of Thoracic Diseases|April 15, 1999
Diagnostic value of endoscopic ultrasonography-guided fine-needle aspiration cytology of mediastinal masses in patients with intrapulmonary lesions and nondiagnostic bronchoscopyA Fritscher-Ravens, S Petrasch, A Reinacher-Schick, et al.Annals of Hematology|October 31, 1998
c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell diseaseA Reinacher-Schick, S Petrasch, B J Longley, et al.Clinical and Diagnostic Laboratory Immunology|January 10, 1998
Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccinesS Petrasch, O Kühnemund, A Reinacher, et al.Endoscopy|March 16, 2000
Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowelA Reinacher-Schick, F Seidensticker, S Petrasch, et al.Wiener Medizinische Wochenschrift (1946)|February 27, 1999
Assessment of satisfaction with the communication process during consultation of cancer patients with potentially curable disease, cancer patients on palliative care, and HIV-positive patientsS Petrasch, M Bauer, A Reinacher-Schick, et al.International Journal of Oral and Maxillofacial Surgery|October 13, 2000
Neoadjuvant, hyperfractionated irradiation induces apoptosis and decreases proliferation in squamous cell cancer of the oral cavityS Petrasch, A Reinacher-Schick, B Busemann, et al.Mund-, Kiefer- Und Gesichtschirurgie : MKG|September 17, 1998
[Management of hematologic systemic diseases and rare tumor entities with manifestations in the oromaxillofacial area]S PetraschHepato-Gastroenterology|December 1, 1989
Biological response modifier--immunotherapeutic approaches in pancreatic cancerW SchmiegelPageof 13